Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Marzo

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 31, 2024
Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experienceSimone Longhi, Elena Biagini, Pietro Guaraldi, et al.
Frontiers in Neurology|September 15, 2025
Monitoring patients and asymptomatic carriers with hereditary transthyretin amyloidosis: regional protocol of Emilia-Romagna ATTR working groupPietro Guaraldi, Isabella Allegri, Alessandra Ariatti, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosisAlberto Aimo, Paolo Milani, Giacomo Tini, et al.
Circulation|April 11, 2022
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute MyocarditisEnrico Ammirati, Laura Lupi, Matteo Palazzini, et al.
JACC. Cardiovascular Imaging|May 25, 2023
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International RegistryGianluca Pontone, Andrea Igoren Guaricci, Laura Fusini, et al.
European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 31, 2024
Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experienceSimone Longhi, Elena Biagini, Pietro Guaraldi, et al.
Frontiers in Neurology|September 15, 2025
Monitoring patients and asymptomatic carriers with hereditary transthyretin amyloidosis: regional protocol of Emilia-Romagna ATTR working groupPietro Guaraldi, Isabella Allegri, Alessandra Ariatti, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosisAlberto Aimo, Paolo Milani, Giacomo Tini, et al.
Circulation|April 11, 2022
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute MyocarditisEnrico Ammirati, Laura Lupi, Matteo Palazzini, et al.
JACC. Cardiovascular Imaging|May 25, 2023
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International RegistryGianluca Pontone, Andrea Igoren Guaricci, Laura Fusini, et al.
European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.
Pageof 4